| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 07/01/1999 | WO1999032451A1 Azepine or larger medium ring derivatives and their use as pharmaceuticals |
| 07/01/1999 | WO1999018801A9 Methods and compositions for the treatment of autoimmune disease using heat shock proteins |
| 07/01/1999 | WO1999016741A3 Lipophilic diesters of chelating agents |
| 06/30/1999 | EP0926148A1 Benzo (C)quinolizine derivatives, their preparation and use as 5-alphareductases inhibitors |
| 06/30/1999 | EP0925791A1 Preventive and/or therapeutic agent for kidney diseases |
| 06/30/1999 | EP0925299A1 Pyrazolopyridine compound and pharmaceutical use thereof |
| 06/30/1999 | EP0925298A1 Substituted 6,6-hetero-bicyclic derivatives |
| 06/30/1999 | EP0925297A1 Endothelin receptor antagonists |
| 06/30/1999 | EP0925069A1 Means for treating prostate hypertrophy and prostate cancer |
| 06/30/1999 | EP0925057A1 Bowman-birk inhibitor for male sexual dysfunction |
| 06/30/1999 | EP0924983A1 S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders |
| 06/30/1999 | CN1221417A Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof |
| 06/29/1999 | US5916887 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 06/24/1999 | WO1999031134A1 Glucose regulated gene |
| 06/24/1999 | WO1999031119A1 Platelet derived growth factor (pdgf) nucleic acid ligand complexes |
| 06/24/1999 | WO1999031059A1 Potassium channel openers |
| 06/24/1999 | WO1999031045A1 Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same |
| 06/24/1999 | WO1999030708A2 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents |
| 06/24/1999 | WO1999030670A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof |
| 06/24/1999 | WO1999030562A1 Method for treating fibroproliferative disorders by inhibitors of protein hydroxylation |
| 06/24/1999 | DE19756388A1 New 2-aryl-4-amino-6,7-di:methoxy-quinazoline derivatives useful as guanylate cyclase activators for treating cardiovascular diseases, etc. |
| 06/24/1999 | CA2314948A1 Potassium channel openers |
| 06/24/1999 | CA2314141A1 Glucose regulated gene |
| 06/24/1999 | CA2312347A1 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents |
| 06/23/1999 | EP0923582A1 Substituted 6,5-hetero-bicyclic derivatives |
| 06/23/1999 | EP0923580A1 Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof |
| 06/23/1999 | EP0923567A1 Benzylamine derivatives, their preparation and their application in therapeutics |
| 06/23/1999 | EP0923536A1 Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation |
| 06/23/1999 | EP0923529A1 Subsitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors |
| 06/23/1999 | CN1043762C Compound used for excitary amino acid receptor antagonists and its drug composition |
| 06/22/1999 | US5914338 Heterocyclic compounds and their preparation and use |
| 06/22/1999 | US5914330 Administering an imidazole-containing pyrimidine derivative effective to protect against renal failure without reducing blood pressure |
| 06/17/1999 | WO1999029685A1 (e)-3-[1-n-butyl- 5-[2-(2-carboxyphenyl)methoxy- 4-chlorophenyl]-1h- pyrazol-4-yl]-2-[(5- methoxy-2,3- dihydrobenzofuran-6-yl)methyl]- prop-2-enoic acid monoargininyl salt |
| 06/17/1999 | WO1999029316A1 Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 06/17/1999 | WO1999029308A2 Method for combating obesity |
| 06/17/1999 | WO1999007695A3 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONIST |
| 06/17/1999 | CA2312965A1 (e)-3-¬1-n-butyl-5-¬2-(2-carboxyphenyl)methoxy-4-chlorophenyl|-1h-pyrazol-4-yl|-2-¬(5-methoxy-2,3-dihydrobenzofuran-6-yl)methyl|-prop-2-enoic acid monoargininyl salt |
| 06/16/1999 | EP0922102A1 Hepatocyte growth factor receptor agonists and uses thereof |
| 06/16/1999 | EP0921815A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 06/16/1999 | EP0921801A1 Inhibitors of farnesyl-protein transferase |
| 06/16/1999 | EP0921800A1 Substituted biphenyl isoxazole sulfonamides |
| 06/16/1999 | EP0921786A1 Nasal administration of desmopressin |
| 06/16/1999 | EP0583421B1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 06/16/1999 | CN1219936A New triazolopurines, method of preparing them and their use as drugs |
| 06/16/1999 | CN1219935A Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 06/16/1999 | CN1219928A Novel vitamin D analogues |
| 06/16/1999 | CN1219872A Compositions and method for treating or preventing diseases of body passageways |
| 06/16/1999 | CN1219395A Traditional Chinese medicine for curing kidney disease and its preparation method |
| 06/16/1999 | CN1043639C New piperidine compounds, process for their preparation and pharmaceutical compositions which contain them |
| 06/15/1999 | US5912335 A polynucleotide sequence that codes human 7-transmembrane receptor protein; treatment of infections, hiv, eating disorders, cancers, heart diseases, mental illnesses, huntington's disease, tourett's and parkinson's disease |
| 06/15/1999 | US5912265 Administering silymarin, silybin, silidianin, silicristin, dehydrosilybin or mixtures; antitumor and anticarcinogenic agents |
| 06/15/1999 | US5912244 Muscle disorders, breathing disorders and urinary incontinence |
| 06/15/1999 | US5912159 An isolated human polypeptide which controls nitric oxide biosynthesis; diagnosis and therapy for urea cycle diseases, hypertension, hypotension, prostate cancer/ hyperplasia/ hypertrophy and kidney diseases |
| 06/15/1999 | US5912005 Methods of use of uncoated gel particles |
| 06/10/1999 | WO1999028493A2 Method for identifying inhibitors of g-protein coupled receptor hibef51 |
| 06/10/1999 | WO1999028475A2 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 06/10/1999 | WO1999028345A1 Conjugates useful in the treatment of prostate cancer |
| 06/10/1999 | WO1999028342A2 Low-voltage activated calcium channel compositions and methods |
| 06/10/1999 | WO1999028315A1 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof |
| 06/10/1999 | WO1999028304A2 Pdgf receptor kinase inhibitory compounds, their preparation and compositions |
| 06/10/1999 | WO1999027927A1 Synergistic antimicrobial compositions |
| 06/10/1999 | WO1999027890A2 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 06/10/1999 | WO1999008684A3 Solutions containing azasteroids |
| 06/10/1999 | WO1999007737A3 Lsr receptor, cloning and uses |
| 06/10/1999 | DE19812413C1 Transdermal therapeutic system for administration of oxybutynin |
| 06/10/1999 | DE19754082A1 Methode zur Bekämpfung der Fettleibigkeit Method to combat obesity |
| 06/10/1999 | CA2312811A1 Synergistic antimicrobial compositions |
| 06/10/1999 | CA2312749A1 Pdgf receptor kinase inhibitory compounds and compositions, method for synthesis of same and use of same for treatment of proliferate disorders |
| 06/10/1999 | CA2312195A1 Low-voltage activated calcium channel compositions and methods |
| 06/10/1999 | CA2311615A1 Conjugates useful in the treatment of prostate cancer |
| 06/10/1999 | CA2310629A1 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof |
| 06/10/1999 | CA2309228A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 06/09/1999 | EP0921124A1 Benzothiophene derivatives useful in therapy |
| 06/09/1999 | EP0920332A1 Use of at least one proteolytic enzyme for treating glomerulonephritis |
| 06/09/1999 | EP0920253A1 Il-8 receptor antagonists |
| 06/09/1999 | EP0751932B1 Vitamin-d amide derivatives |
| 06/09/1999 | CN1219172A Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 06/08/1999 | US5910574 Human trk receptors and neurotrophic factor inhibitors |
| 06/08/1999 | US5910451 Trophinin and trophinin-assisting proteins |
| 06/08/1999 | US5910437 Ligated d-protein of formula r-l-r' where r and r' are peptides and l is linking group of thiol ester or selenol ester; for production of chirally pure chemicals and drugs; production of racemic crystals; prolonged half-life in body |
| 06/08/1999 | US5910316 Concentrated and localized release of no at a given site in a controllable and predictable manner such that effective dosing can be realized |
| 06/08/1999 | US5910305 Process for enhancing fetus fixation of a pregnant animal to prevent abortion |
| 06/08/1999 | CA2255165A1 Benzothiophene derivatives useful in therapy |
| 06/08/1999 | CA2242308A1 Novel compounds |
| 06/03/1999 | WO1999027098A2 A-33 related antigens and their pharmacological uses |
| 06/03/1999 | WO1999026909A2 Alpha-hydroxy, -amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors |
| 06/03/1999 | WO1999026650A1 ribB |
| 06/03/1999 | WO1999026647A1 Use of heparin-binding protein for the modulation or prophylaxis of apoptosis of mammalian cells |
| 06/03/1999 | WO1999026646A1 ribA |
| 06/03/1999 | WO1999026628A1 Use of substituted 11-phenyl-dibenzazepine compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scour |
| 06/03/1999 | WO1999026624A1 Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhe and scours |
| 06/03/1999 | CA2311129A1 Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scours |
| 06/03/1999 | CA2310773A1 Use of substituted 11-phenyl-dibenzazepine compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scour |
| 06/03/1999 | CA2310401A1 Alpha-hydroxy, -amino and -halo derivatives of beta-sulfone hydroxamates as matrix metalloproteinase inhibitors |
| 06/03/1999 | CA2309358A1 A-33 related antigens and their pharmacological uses |
| 06/02/1999 | EP0919234A2 Potentiation of pharmaceuticals by moxonidine |
| 06/02/1999 | EP0918855A1 Polycystic kidney disease gene |
| 06/02/1999 | EP0918771A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase |
| 06/02/1999 | EP0918532A1 A novel method of detecting and treating cancer |
| 06/02/1999 | EP0757718A4 Methods of use of uncoated gel particles |